NCT05231330 is a NA clinical trial of silvernanoparticles in Caries,Dental, sponsored by Suez Canal University.

Who is sponsoring NCT05231330?

NCT05231330 is sponsored by Suez Canal University.

What drugs are being tested in NCT05231330?

Interventions in NCT05231330: silvernanoparticles, SDF.

What condition does NCT05231330 study?

NCT05231330 studies Caries,Dental.

Is NCT05231330 still recruiting?

NCT05231330 is currently completed. Last updated 9 February 2022.

Last reviewed 2022-02-09 · How we verify

NCT05231330

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of Silver Nanoparticles in Comparison to Silver Diamine Fluoride in Management of Deep Carious Lesions

Completed NA Last updated 9 February 2022

What this trial tests

NA trial testing silvernanoparticles in Caries,Dental in 36 participants. Completed in 1 March 2021.

Timeline

1 March 2020

Primary endpoint
1 October 2020

1 March 2021

Quick facts

Lead sponsor	Suez Canal University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	36
Start date	1 March 2020
Primary completion	1 October 2020
Estimated completion	1 March 2021
Sites	1 location across Egypt

Drugs / interventions tested

silvernanoparticles — full drug profile →
SDF — full drug profile →

Conditions studied

Caries,Dental — all drugs for Caries,Dental →

Sponsor

Suez Canal University

Who can join

Adults 18 to 50, any sex, with Caries,Dental. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this clinical study will be carried out to evaluate the effect of fluoride varnish with silver nanoparticles in comparison to silver diamine fluoride in management of deep carious lesions.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Current Overview of Metal Nanoparticles' Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles.
Burlec AF, Corciova A, Boev M, Batir-Marin D, et al · · 2023 · cited 93× · PMID 37895881 · DOI 10.3390/ph16101410
New Technological Approaches for Dental Caries Treatment: From Liquid Crystalline Systems to Nanocarriers.
Luiz MT, di Filippo LD, Dutra JAP, Viegas JSR, et al · · 2023 · cited 15× · PMID 36986624 · DOI 10.3390/pharmaceutics15030762

Verify or expand the search:

Other recruiting trials for Caries,Dental

Currently open trials in the same condition.

NCT07323433 — Efficacy of a Chitosan Dressing in Pulpotomy of Immature Permanent Teeth · NA · recruiting
NCT06690229 — Evaluation of Different Cementation Materials Used in Prefabricated Pediatric Zirconia Crowns · NA · active not recruiting
NCT06453005 — Comparative Evaluation of SMART Hall Technique Vs. Conventional SS Crown in Primary Molars: a Randomized Clinical Trial · NA · recruiting
NCT05860712 — Evaluation of Antimicrobial, Post Operative Pain of Cinnamon Extract Versus Sodium Hypochlorite Irrigant Following Pulpe · NA · recruiting
NCT05969756 — Early Treatments for Preventing Occlusal Caries Lesions · NA · active not recruiting

Other Suez Canal University trials

Trials by the same sponsor.

NCT07263893 — Inter Flex Three Dimensional Plate in Management of Mandibular Fracture RCT · NA · recruiting
NCT07280533 — Accuracy of Virtual Surgical Planning Versus Traditional Technique in Zygomaticomaxillary Fracture Reduction · NA · not yet recruiting
NCT07291791 — tDCS for Pain Modulation in Knee Osteoarthritis · NA · active not recruiting
NCT07262086 — Clinical Evaluation of Wear Resistance and Bioactivity of Self Cured Bioactive Resin Composite · NA · enrolling by invitation
NCT07125846 — Efficacy of Bioactive Glass vs. Xenograft in Maxillary Sinus Augmentation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05231330 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Suez Canal University
Last refreshed: 9 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05231330.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing